Biomagnetics (BMGP) Enters Chinese Biotech Market
Biomagnetics Diagnostics Corp. announced they have formed a joint venture with Dr. Hai Shiene Chen and ACGT DNA Technologies Corporation, a company in Canada's DNA industry with extensive ties to China’s medical industry. The company will focus on the creation of a separate Chinese Corporation (a subsidiary of BMGP) to establish a functioning presence in China. ACGT currently has a separate operating division based in China. The goal is to use their expertise and connections to help form BMGP’s Chinese division and qualify it for funding assistance from the Chinese government’s high tech Incubator Program.
BMGP plans explore stem cell and genetic engineering application opportunities within China. Unlike the United States, China has no restrictions on stem cell research. Couple that with a highly trained and skilled labor force makes China ideal for biotechnology development.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.